Only 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.

Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison / Marra, Giancarlo; Soeterik, Timo; Oreggia, Davide; Tourinho-Barbosa, Rafael; Moschini, Marco; Stabile, Armando; Filippini, Claudia; van Melick, Harm He; van den Bergh, Roderick Cn; Gontero, Paolo; Pasquali, Caio; Macek, Petr; Cathala, Nathalie; Sanchez-Salas, Rafael; Cathelineau, Xavier. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1938-0682. - 20:6(2022), pp. 592-604. [10.1016/j.clgc.2022.06.009]

Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison

Marra, Giancarlo;Gontero, Paolo;
2022

Abstract

Only 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.
File in questo prodotto:
File Dimensione Formato  
89 - Clin Gen Ca HIFU def.pdf

non disponibili

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: Non Pubblico - Accesso privato/ristretto
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11583/2983456